Skip to main content

Table 1 Characteristics of the study cohort

From: Faecalibacterium prausnitzii as a potential Antiatherosclerotic microbe

Variable

MI (n = 53)

UA (n = 106)

SCAD (n = 56)

Control (n = 156)

P value

Age, yr *

60 ± 12

60 ± 11

60 ± 10

57 ± 11

0.56

Male,n #

43 (81.13%)

70 (66.04%)

33 (58.93%)

77 (49.36%)

< 0.001 a b

Body mass index, kg/m2+

25.69 (3.81)

25.14 (5.1)

25.15 (4.84)

25 (5.48)

0.828

Systolic blood pressure, mmHg +

128 (22)

131 (24)

124 (27)

124 (22)

0.021 b

diastolic blood pressure, mmHg +

77 (16)

76 (16)

73 (17)

75 (12)

0.51

Smoking status

    

< 0.001a e

Never or Past #

31 (58.49%)

62 (58.49%)

38 (67.86%)

127 (81.41%)

 

Current #

22 (41.51%)

44 (41.51%)

18 (32.14%)

29 (18.59%)

 

Drinking status

    

< 0.001a b

 Non-heavy Drinker #

25 (47.17%)

73 (68.87%)

38 (67.86%)

123 (78.85%)

 

 Heavy Drinker #

28 (52.83%)

33 (31.13)

18 (32.14%)

33 (21.15%)

 

Basic diseases

     

 Hypertension #

35 (66.04%)

63 (59.43%)

37 (66.07%)

65 (41.67%)

0.001a b c

 Diabetes #

23 (43.4%)

34 (32.08%)

17 (30.36%)

21 (13.46%)

< 0.001a b c

Long term oral medication

     

 Aspirin #

46 (86.79%)

88 (83.02%)

42 (75%)

60 (38.46%)

< 0.001a b c

 Clopidogrel #

33 (62.26%)

69 (65.09%)

37 (66.07%)

8 (5.13%)

< 0.001a b c

 Stain #

44 (83.02%)

81 (76.42%)

47 (82.93%)

67 (42.95%)

< 0.001a b c

 β-block #

38 (71.7%)

64 (60.38%)

34 (60.71%)

46 (29.49%)

< 0.001a b c

 Calcium Channel Blockers #

8 (15.09%)

26 (24.53%)

17 (30.36%)

29 (18.59%)

0.155

 ACEI or ARB #

25 (47.17%)

37 (34.91%)

26 (46.43%)

35 (22.44%)

0.001a c

Laboratory results

     

 Blood Urea Nitrogen, mmol/L +

5.05 (2.73)

5.11 (2.1)

5.4 (1.4)

5.05 (1.8)

0.26

 Creatinine, umol/L +

71.5 (20.28)

66 (23)

62 (22.84)

62 (19)

< 0.001a d e

 Uric Acid, umol/L +

333 (141.25)

308 (109)

327 (123)

310 (111)

0.111

 Glucose, mmol/L +

5.29 (2.87)

5.19 (2.07)

4.84 (1.9)

4.76 (0.82)

< 0.001a b

 Triglyceride, mmol/L +

1.48 (1.03)

1.37 (0.99)

1.57 (1.18)

1.32 (0.88)

0.114

 Total cholesterol, mmol/L +

3.47 (1.36)

3.34 (1.26)

3.42 (1.29)

3.96 (1.18)

0.001b

 High Density Lipoprotein, mmol/L +

1.04 (0.31)

1.02 (0.39)

1.06 (0.41)

1.14 (0.46)

0.002a b

 Low Density Lipoprotein, mmol/L +

2.09 (1.31)

2.03 (1.05)

1.84 (1.17)

2.53 (1.06)

< 0.001b c

 Apolipoprotein AI, g/L *

0.99 ± 0.22

1.0 ± 0.33

1.1 ± 0.29

1.1 ± 0.28

0.002a b

 Apolipoprotein B, g/L *

0.91 ± 0.31

0.87 ± 0.29

0.89 ± 0.31

0.96 ± 0.29

0.08

 Lipoprotein(a), mg/L +

195.02 (247.72)

125.89 (245.44)

123.2 (161.8)

105.35 (180.23)

0.124

  1. Continuous, normally distributed variables among the four groups were analysed by a one-way analysis of variance. The Kruskal-Wallis H-test was applied for data of this type that were not normally distributed. Continuous, normally distributed variables between two groups were analysed by Student’s t-test. The MannWhitney U test was applied for data of this type that were not normally distributed. Categorical variables were compared by the χ2 test. N/A not available. Drinking history is defined as patients who consumed ≥50 g of alcohol per day
  2. + median (IQR), * mean ± SD, # n (%)
  3. aP <  0.05 for equality between MI vs. control. bP <  0.05 for equality between UA vs. control. cP <  0.05 for equality between SCAD vs. control. dP <  0.05 for equality between SCAD vs. MI. eP <  0.05 for equality between UA vs. MI